Exhibit 99.2
Report of Voting Results
In accordance with Section 11.3 of National Instrument 51-102 – Continuous Disclosure Obligations, we advise of the results of the voting on the matters submitted to the annual general meeting (“Meeting”) of the shareholders of Eupraxia Pharmaceuticals Inc. (“Company”) held on June 18, 2026.
The matters voted on at the Meeting and the results of the voting were as follows:
Item 1: Number of Directors
On a vote by ballot, the shareholders approved setting the number of directors at seven.
| Votes For | % For | Votes Against | % Against |
| 24,492,802 | 99.983 | 4,161 | 0.017 |
Item 2: Election of Directors
On a vote by ballot, the following nominees were elected as directors to serve until the next annual meeting of shareholders of the Company or until his or her successor is duly elected or appointed.
| Director Nominee | Votes For | % For | Votes Withheld | % Withheld |
| James A. Helliwell | 19,815,199 | 99.784 | 42,865 | 0.216 |
| Simon Pimstone | 18,091,080 | 91.102 | 1,766,984 | 8.898 |
| Richard M. Glickman | 19,443,941 | 97.915 | 414,123 | 2.085 |
| John Montalbano | 19,470,318 | 98.047 | 387,746 | 1.953 |
| Joseph Freedman | 19,828,021 | 99.849 | 30,043 | 0.151 |
| Amy Pott | 19,828,243 | 99.850 | 29,821 | 0.150 |
| Robert Bazemore | 19,853,021 | 99.975 | 5,043 | 0.025 |
Item 3: Appointment of Auditors
On a vote by ballot, the shareholders re-appointed KPMG LLP as auditor of the Company for the ensuing year and authorized the directors to set the auditor’s pay.
| Votes For | % For | Votes Withheld | % Withheld |
| 24,409,660 | 99.644 | 87,302 | 0.356 |
Yours truly,
Eupraxia Pharmaceuticals Inc.
(signed) “James A. Helliwell”___
Chief Executive Officer